Your browser doesn't support javascript.
loading
The Role of redo-Sentinel Lymph Node Biopsy in Patients With Prior Ipsilateral Breast Cancer Surgery.
Macnab, Margo-Rose F; Slater, Gabrielle; Fuller, Mairi; Elsberger, Beatrix; Lovell, Lesley; Staff, Roger T; Masannat, Yazan A.
Afiliación
  • Macnab MF; Nuclear Medicine Department, Aberdeen Royal Infirmary, Aberdeen, Scotland, UK.
  • Slater G; The School of Medicine, Medical Sciences and Nutrition, University of Aberdeen, Aberdeen, Scotland, UK.
  • Fuller M; The School of Medicine, Medical Sciences and Nutrition, University of Aberdeen, Aberdeen, Scotland, UK; The Breast Unit, Aberdeen Royal Infirmary, Aberdeen, Scotland, UK.
  • Elsberger B; The School of Medicine, Medical Sciences and Nutrition, University of Aberdeen, Aberdeen, Scotland, UK; The Breast Unit, Aberdeen Royal Infirmary, Aberdeen, Scotland, UK.
  • Lovell L; Nuclear Medicine Department, Aberdeen Royal Infirmary, Aberdeen, Scotland, UK.
  • Staff RT; Nuclear Medicine Department, Aberdeen Royal Infirmary, Aberdeen, Scotland, UK.
  • Masannat YA; The School of Medicine, Medical Sciences and Nutrition, University of Aberdeen, Aberdeen, Scotland, UK; The Breast Unit, Aberdeen Royal Infirmary, Aberdeen, Scotland, UK. Electronic address: yazanmas@hotmail.com.
Clin Breast Cancer ; 22(5): e674-e679, 2022 07.
Article en En | MEDLINE | ID: mdl-35279407
BACKGROUND: Sentinel Lymph Node Biopsy (SLNB) is used to stage the axilla, but there is limited data in patients with prior ipsilateral breast cancer. This study compares redo-SLNB (reSLNB) and Axillary node sample (ANS) in this sub-cohort of patients. MATERIALS AND METHODS: This is a retrospective study looking at patients with a new ipsilateral primary or recurrence with history of breast-conserving surgery. Planned and performed surgery, patient demographics and previous treatments were recorded. Node positivity and success rate of reSLNB was analyzed. RESULTS: A total of 86 patients were identified that had mastectomy for ipsilateral recurrent disease with radiologically negative axilla. Out of the 48 that had reSLNB, 35(72.9%) were successful. Nineteen percent of the reSLNB had positive axillae and 20% of the ANS patients. reSLNB success rate was significantly lower amongst patients with previous axillary surgery (P = .014) and previous positive nodes(P = .001). CONCLUSION: reSLNB should be considered to restage the axilla in patients with previous history of ipsilateral cancer especially that there is growing evidence showing good identification rate.
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Biopsia del Ganglio Linfático Centinela Tipo de estudio: Observational_studies / Prognostic_studies Límite: Female / Humans Idioma: En Revista: Clin Breast Cancer Asunto de la revista: NEOPLASIAS Año: 2022 Tipo del documento: Article Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Biopsia del Ganglio Linfático Centinela Tipo de estudio: Observational_studies / Prognostic_studies Límite: Female / Humans Idioma: En Revista: Clin Breast Cancer Asunto de la revista: NEOPLASIAS Año: 2022 Tipo del documento: Article Pais de publicación: Estados Unidos